Tert-butyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate;tert-butyl piperazine-1-carboxylate;4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-methylpyrazol-1-yl)pyrimidin-2-amine;methyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate
C66H94ClF6N21O6 — CID 158631839
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate;tert-butyl piperazine-1-carboxylate;4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-methylpyrazol-1-yl)pyrimidin-2-amine;methyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate
Tert-butyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate;tert-butyl piperazine-1-carboxylate;4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-methylpyrazol-1-yl)pyrimidin-2-amine;methyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate (PubChem CID 158631839) has the molecular formula C66H94ClF6N21O6 and a molecular weight of 1427.06 g/mol. Its IUPAC name is tert-butyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate;tert-butyl piperazine-1-carboxylate;4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-methylpyrazol-1-yl)pyrimidin-2-amine;methyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate;tert-butyl piperazine-1-carboxylate;4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-methylpyrazol-1-yl)pyrimidin-2-amine;methyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate |
|---|---|
| PubChem CID | 158631839 |
| Molecular Formula | C66H94ClF6N21O6 |
| Molecular Weight | 1427.06 g/mol |
| Exact Mass | 1425.73 |
| IUPAC Name | tert-butyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate;tert-butyl piperazine-1-carboxylate;4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-methylpyrazol-1-yl)pyrimidin-2-amine;methyl 4-[2-[(4,4-difluorocyclohexyl)amino]-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CCNCC1.COC(=O)N1CCN(c2cc(-n3ccc(C)n3)nc(NC3CCC(F)(F)CC3)n2)CC1.Cc1ccn(-c2cc(Cl)nc(NC3CCC(F)(F)CC3)n2)n1.Cc1ccn(-c2cc(N3CCN(C(=O)OC(C)(C)C)CC3)nc(NC3CCC(F)(F)CC3)n2)n1 |
| InChI | InChI=1S/C23H33F2N7O2.C20H27F2N7O2.C14H16ClF2N5.C9H18N2O2/c1-16-7-10-32(29-16)19-15-18(27-20(28-19)26-17-5-8-23(24,25)9-6-17)30-11-13-31(14-12-30)21(33)34-22(2,3)4;1-14-5-8-29(26-14)17-13-16(27-9-11-28(12-10-27)19(30)31-2)24-18(25-17)23-15-3-6-20(21,22)7-4-15;1-9-4-7-22(21-9)12-8-11(15)19-13(20-12)18-10-2-5-14(16,17)6-3-10;1-9(2,3)13-8(12)11-6-4-10-5-7-11/h7,10,15,17H,5-6,8-9,11-14H2,1-4H3,(H,26,27,28);5,8,13,15H,3-4,6-7,9-12H2,1-2H3,(H,23,24,25);4,7-8,10H,2-3,5-6H2,1H3,(H,18,19,20);10H,4-7H2,1-3H3 |
| InChIKey | HZHGHLDUPSWFKN-UHFFFAOYSA-N |
| XLogP | 11.31 |
| TPSA | 274.02 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 100 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1427.06 |
| LogP ≤ 5 | 11.31 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 24 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158631839 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.